Humana (HUM) Liabilities and Shareholders Equity (2009 - 2026)

Humana's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $55.3 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 8.54% year-over-year to $55.3 billion; the TTM figure through Mar 2026 stood at $204.3 billion (up 3.42% YoY), while the FY2025 annual figure was $48.9 billion, up 5.23% from the prior year.
• Liabilities and Shareholders Equity was $55.3 billion for Q1 2026 at Humana, up from $48.9 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $56.5 billion in Q2 2023 to a low of $43.1 billion in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $50.2 billion across 5 years, with a median of $50.1 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity rose 23.77% in 2022, then retreated 11.27% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $43.1 billion in 2022, then gained by 9.31% to $47.1 billion in 2023, then retreated by 1.25% to $46.5 billion in 2024, then increased by 5.23% to $48.9 billion in 2025, then rose by 13.03% to $55.3 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $55.3 billion (Q1 2026), $48.9 billion (Q4 2025), and $49.7 billion (Q3 2025), per Business Quant data.